First Page | Document Content | |
---|---|---|
Date: 2016-12-05 13:18:26 | A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date DanAdd to Reading ListSource URL: glycomimetics.comDownload Document from Source WebsiteFile Size: 1,05 MBShare Document on Facebook |